CSIMarket
Galectin Therapeutics Inc   (GALT)
Other Ticker:  
 
 

Galectin Therapeutics Inc 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



GALT Annual Income from Cont. Operations Growth

2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change - - - - -
Annual Income from Cont. Operations (in millions $) $-44.69 $-38.78 $-30.53 $-23.47 $-19.92


Annual Income from Cont. Operations Growth Comment
Galectin Therapeutics Inc realized loss from Cont. Operations.

Galectin Therapeutics Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2023 Annual Income from Cont. Operations
Merck and Co Inc -97.49 %$ 365.000  millions
Avantor Inc -53.23 %$ 321.100  millions
Henry Schein Inc -22.97 %$ 436.000  millions
Revvity Inc -64.99 %$ 179.503  millions
Catalent Inc